What is Biogen known for?
Who We Are. At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
What’s new at Biogen and Eisai?
Biogen and Eisai receive FDA accelerated approval for a new therapy targeting amyloid beta plaque. When Mayu’s doctor diagnosed her with MS, she faced the challenges of being a new mother and the fear of losing her ability to play the piano.
How can I contact a Biogen employee?
We work together to bring life-changing therapies to patients every day. Start here to find the fulfilling career opportunity that’s right for you. Please be advised that all legitimate correspondence from a Biogen employee will come from “@biogen.com” or “@brassring.com” email accounts.
Are there any third party sites that Biogen does not endorse?
Third Party Sites. Biogen assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site’s endorsement of Biogen or this website.
How do I contact Biogen for product support outside of the US?
For product support in countries outside of the U.S., please contact the Biogen affiliate in your country or email [email protected] if your country is not represented. Your doctor should always be the primary resource regarding treatment options.
Would you like to partner with Biogen?
Partnerships and collaborations are critical to building our neuroscience innovation ecosystem and we welcome the opportunity to explore working with other innovators. If your company or institution would like to share a potential asset or platform technology for collaboration, contact us today at [email protected].
What is Biogen’s gene therapy accelerator unit?
For Junghae Suh, head of Biogen’s Gene Therapy Accelerator Unit, it’s about working to deliver potentially life-transforming gene therapy medicines to patients. Biogen is committed to the power of diversity – in our organization and among our patients and customers.
How do I get product support for Biogen products?
This product support information is applicable to patients who have been prescribed Biogen therapies in the United States only. For product support in countries outside of the U.S., please contact the Biogen affiliate in your country or email [email protected] if your country is not represented.
How do I report a compliance issue with Biogen?
If you wish to report any compliance concerns regarding Biogen or any of its employees or contractors, you may do so in writing at the address provided below or confidentially and anonymously, where permitted by local law, by using the Compliance Helpline.
Does Biogen have a new Alzheimer’s disease treatment?
On October 22, 2019, Biogen announced that, after consulting with the U.S. Food and Drug Administration (FDA), Biogen plans to pursue regulatory approval for aducanumab, an investigational treatment for early Alzheimer’s disease. Read the full press release. Learn more about the aducanumab announcement.